Remedium Lifecare Ltd Stock Price Today (NSE: REMLIFE)
Fundamental Score
Remedium Lifecare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Remedium Lifecare Ltd share price today is ₹0.36, up +0.00% on NSE/BSE as of 18 June 2026. Remedium Lifecare Ltd (REMLIFE) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of ₹95.26 (Cr). The 52-week high for REMLIFE share price is ₹1.80 and the 52-week low is ₹0.36. At a P/E ratio of 44.72x, REMLIFE is currently trading above its industry average P/E of 35.45x.
Remedium Lifecare Ltd Share Price Chart — NSE/BSE Historical Performance
Remedium Lifecare Ltd share price chart: -60.00% return over the past month. 52-week high ₹1.80, 52-week low ₹0.36.
Remedium Lifecare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹0.36 | ₹0.36 | ₹0.36 | ₹0.36 | 29.68L (Cr) | |
| ₹0.37 | ₹0.37 | ₹0.37 | ₹0.37 | 30.31L (Cr) | |
| ₹0.38 | ₹0.38 | ₹0.38 | ₹0.38 | 31.75L (Cr) | |
| ₹0.40 | ₹0.42 | ₹0.39 | ₹0.39 | 101.84L (Cr) | |
| ₹0.42 | ₹0.42 | ₹0.41 | ₹0.41 | 139.17L (Cr) | |
| ₹0.45 | ₹0.47 | ₹0.43 | ₹0.43 | 172.25L (Cr) | |
| ₹0.45 | ₹0.45 | ₹0.45 | ₹0.45 | 96.69L (Cr) | |
| ₹0.47 | ₹0.47 | ₹0.44 | ₹0.47 | 398.31L (Cr) | |
| ₹0.45 | ₹0.45 | ₹0.44 | ₹0.45 | 215.42L (Cr) | |
| ₹0.41 | ₹0.43 | ₹0.40 | ₹0.43 | 172.64L (Cr) |
Remedium Lifecare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹0.70 | ₹0.70 | ₹0.36 | ₹0.36 | -48.57% | |
| ₹0.89 | ₹0.98 | ₹0.68 | ₹0.68 | -23.60% | |
| ₹0.84 | ₹0.93 | ₹0.69 | ₹0.83 | -1.19% | |
| ₹1.14 | ₹1.14 | ₹0.75 | ₹0.75 | -34.21% | |
| ₹1.54 | ₹1.66 | ₹1.13 | ₹1.14 | -25.97% | |
| ₹1.47 | ₹1.80 | ₹1.44 | ₹1.56 | +6.12% | |
| ₹1.31 | ₹1.61 | ₹1.24 | ₹1.47 | +12.21% | |
| ₹1.33 | ₹1.35 | ₹1.15 | ₹1.31 | -1.50% | |
| ₹1.02 | ₹1.31 | ₹0.99 | ₹1.31 | +28.43% | |
| ₹0.99 | ₹0.99 | ₹0.80 | ₹0.98 | -1.01% |
AI Research Briefing
Powered by Gemini · 2026-04-08
Remedium Lifecare is a value trap facing imminent insolvency risk.
WHAT'S HAPPENING NOW
Remedium Lifecare faces significant headwinds. Supha Pharmachem, a key part of Remedium, has entered insolvency proceedings. A public announcement regarding the NCLT insolvency order was issued in late March. 8% drop from the high of .
CORE STORY
Distressed micro-cap trading play, heavily reliant on API trading, now facing insolvency risk in its core operating subsidiary.
- Supha Pharmachem insolvency proceedings
- Weak financials: high debt, low interest coverage
- Minimal promoter holding
- Successful restructuring and debt resolution
- Acquisition by a stronger player
- Unexpected turnaround in API market conditions
- Insolvency of Supha Pharmachem
- Micro/SME cap: high liquidity risk
- High debt and poor interest coverage
Promoter holding is negligible (1.13%) [cite: Brief], indicating a lack of confidence.
The trading and distribution sector in India faces headwinds due to global economic uncertainty.
Negative: Free cash flow is negligible [cite: Brief].
The company's future hinges on resolving the insolvency. Without a successful restructuring, the stock is likely to decline further. Expect continued volatility.
Primary Thesis Risk
Supha Pharmachem's insolvency will likely bankrupt Remedium Lifecare.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Remedium Lifecare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Remedium Lifecare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of REMLIFE across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Premium Valuation Risk (P/E: 44.72x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Elevated Debt Levels (D/E: 10.34)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (1.57x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Low Promoter Commitment (1.13%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Remedium Lifecare Ltd vs Trading & Distributors Peers
Peer Comparison - Trading & Distributors
Compare Remedium Lifecare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Remedium Lifecare LtdRemedium Lifeca...Selected✓ REMLIFE • 539561 | 0/100 | ₹0.36₹0 | ₹95.26₹95.26 | 44.72Average 44.7 Average | — — | — — | 10.34Poor 10.3 Poor | — — | — — | 0.00% |
Redington LtdRedington Ltd... REDINGTON • 532805 | 58.5/100 | ₹222.80₹223 | ₹22049.92₹22049.92 | 16.14Average 16.1 Average | 14.39%Average 14.39% Average | 18.90%Good 18.90% Good | 0.29Excellent 0.3 Excellent | 17.72%Excellent 17.72% Excellent | 14.06%Good 14.06% Good | 2.41% |
MMTC LtdMMTC Ltd... MMTC • 513377 | 32.1/100 | ₹65.99₹66 | ₹8949.04₹8949.04 | 127.30Average 127.3 Average | 5.87%Poor 5.87% Poor | 7.70%Poor 7.70% Poor | 0.02Excellent 0.0 Excellent | 19.08%Excellent 19.08% Excellent | -86.52%Poor -86.52% Poor | 0.00% |
MSTC LtdMSTC Ltd... MSTCLTD • 542597 | 63.7/100 | ₹438.75₹439 | ₹3458.41₹3458.41 | 15.65Average 15.7 Average | 28.37%Excellent 28.37% Excellent | 29.26%Excellent 29.26% Excellent | 0.17Excellent 0.2 Excellent | 15.18%Excellent 15.18% Excellent | -24.06%Poor -24.06% Poor | 8.24% |
BN Holdings LtdBN Holdings Ltd... BNHOLDINGS • 526125 | 24.7/100 | ₹404.70₹405 | ₹3333.57₹3333.57 | 49.50Average 49.5 Average | 26.05%Excellent 26.05% Excellent | 27.44%Excellent 27.44% Excellent | 0.20Excellent 0.2 Excellent | — — | — — | 0.00% |
Vintage Coffee And Beverages IncVintage Coffee ... VINCOFE • 538920 | 11.1/100 | ₹154.05₹154 | ₹2132.64₹2132.64 | 35.45Average 35.5 Average | 17.05%Good 17.05% Good | 15.42%Good 15.42% Good | 0.17Excellent 0.2 Excellent | — — | — — | 0.06% |
TCC Concept LtdTCC Concept Ltd... TCC • 512038 | 34.8/100 | ₹379.00₹379 | ₹1813.06₹1813.06 | 38.36Average 38.4 Average | 9.28%Poor 9.28% Poor | 11.83%Average 11.83% Average | 0.05Excellent 0.1 Excellent | — — | — — | 0.00% |
Euro Asia Exports LtdEuro Asia Expor... EUROASIA • 530929 | 66.6/100 | ₹637.25₹637 | ₹1297.46₹1297.46 | 518.98Average 519.0 Average | 87.02%Excellent 87.02% Excellent | 82.72%Excellent 82.72% Excellent | 0.00Excellent 0.0 Excellent | 158.76%Excellent 158.76% Excellent | 66.77%Excellent 66.77% Excellent | 0.00% |
41.9/100 | ₹18.76₹19 | ₹1111.34₹1111.34 | 402.66Average 402.7 Average | 1.24%Poor 1.24% Poor | 2.46%Poor 2.46% Poor | 0.06Excellent 0.1 Excellent | 61.76%Excellent 61.76% Excellent | 35.83%Excellent 35.83% Excellent | 0.00% | |
Yamuna Syndicate LtdYamuna Syndicat... YSL • 540980 | 32.3/100 | ₹30300.00₹30300 | ₹1021.99₹1021.99 | 11.71Average 11.7 Average | 9.31%Poor 9.31% Poor | 9.39%Poor 9.39% Poor | 0.00Excellent 0.0 Excellent | 10.82%Good 10.82% Good | 4.86%Average 4.86% Average | 1.50% |
Oswal Agro Mills LtdOswal Agro Mill... OSWALAGRO • 500317 | 62.3/100 | ₹45.83₹46 | ₹811.32₹811.32 | 6.43Average 6.4 Average | 12.62%Average 12.62% Average | 16.29%Good 16.29% Good | 0.00Excellent 0.0 Excellent | 28.35%Excellent 28.35% Excellent | 61.75%Excellent 61.75% Excellent | 0.00% |
Top Trading & Distributors Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Redington Ltd share price22049.92 Cr
- MMTC Ltd share price8949.04 Cr
- MSTC Ltd share price3458.41 Cr
- BN Holdings Ltd share price3333.57 Cr
- Vintage Coffee And Beverages Inc share price2132.64 Cr
Remedium Lifecare Ltd PE Ratio History
Historical price-to-earnings ratio for REMLIFE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.03 | ₹0.75 | 21.5x |
| FY 2024 | ₹0.57 | ₹5.12 | 9x |
| FY 2023 | ₹2.63 | ₹25.07 | 9.5x |
| FY 2022 | ₹0.02 | ₹1.26 | 67.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Remedium Lifecare Ltd Quarterly Performance
Latest quarterly metrics for REMLIFE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Remedium Lifecare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for REMLIFE — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Remedium Lifecare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Remedium Lifecare Ltd (REMLIFE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Remedium Lifecare Ltd
About REMLIFE (Remedium Lifecare Ltd)
Remedium Lifecare Ltd is a prominent player in the trading and distribution sector, specializing in pharmaceutical raw materials and specialty chemicals. The company operates as a ...crucial link in the supply chain, sourcing and delivering vital ingredients to manufacturers across diverse industries. Their product portfolio encompasses a wide array of chemicals, solvents, and reagents, carefully selected to meet stringent quality standards and regulatory requirements. Remedium Lifecare focuses on building strong relationships with both suppliers and customers, ensuring a reliable and efficient flow of essential materials to support manufacturing processes. They are a dynamic organization committed to providing effective sourcing solutions for pharmaceutical and industrial raw materials. Their core business revolves around the procurement, storage, and distribution of these specialized products, enabling manufacturers to access high-quality materials promptly and cost-effectively. Remedium Lifecare Ltd focuses on providing value to its partners through streamlined logistics, responsive customer service, and a deep understanding of market dynamics. By leveraging their extensive network and industry expertise, they facilitate seamless transactions and contribute to the smooth functioning of manufacturing operations. The company actively seeks to expand its product offerings and geographical reach, consistently adapting to evolving customer needs and market trends. Remedium Lifecare is committed to maintaining the highest standards of integrity and compliance in all its operations. The company operates with a strong emphasis on ethical business practices, ensuring transparency and accountability in all dealings. They strive to be a trusted partner to their customers, providing expert guidance and tailored solutions to meet their specific requirements. By fostering long-term relationships built on trust and mutual respect, Remedium Lifecare aims to solidify its position as a leading player in the pharmaceutical raw materials and specialty chemicals trading and distribution sector.
Company Details
Key Leadership
Latest News
REMLIFE Share Price: Frequently Asked Questions
What is the current share price of Remedium Lifecare Ltd?
Remedium Lifecare Ltd (REMLIFE) trades at ₹0.36 on NSE and BSE. Market cap ₹95.26 (Cr). Educational data only.
What is the P/E ratio of Remedium Lifecare Ltd?
Remedium Lifecare Ltd has a P/E of 44.72x vs industry average 35.45x.
What is the Bull Run score for Remedium Lifecare Ltd?
Remedium Lifecare Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Remedium Lifecare Ltd pay dividends?
Remedium Lifecare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Remedium Lifecare Ltd?
Remedium Lifecare Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Remedium Lifecare Ltd?
Remedium Lifecare Ltd has debt-to-equity of 10.34.
Is Remedium Lifecare Ltd a good investment?
Bull Run gives Remedium Lifecare Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.